Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2232 Target Snapshot

Proprotein convertase subtilisin/kexin type 7 · SINGLE PROTEIN · Homo sapiens

25Compounds
10Assays
2Approved Drugs
21.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q16549. Use UniProt Q16549 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q16549 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Proprotein convertase subtilisin/kexin type 7 as ChEMBL target CHEMBL2232, mapped to UniProt Q16549. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Proprotein convertase subtilisin/kexin type 7
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2232
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q16549
Proprotein convertase subtilisin/kexin type 7
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Proprotein convertase subtilisin/kexin type 7 is the right protein anchor across sources, using UniProt Q16549 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProprotein convertase subtilisin/kexin type 7
UniProt AccessionQ16549
Component TypeProtein
Sequence Length785 aa

Proprotein convertase subtilisin/kexin type 7

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Proprotein convertase subtilisin/kexin type 7, mapped to UniProt Q16549. Sequence length is 785 aa.

Mapped IDQ16549
Review nameProprotein convertase subtilisin/kexin type 7
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
Assay Mix

Activity Type Distribution

IC507.0
KI14.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3126388 9.92 Ki 0.12 Preclinical
CHEMBL3115771 7.86 Ki 13.8 Preclinical
CHEMBL3115770 7.14 Ki 72.0 Preclinical
CHEMBL502642 6.87 Ki 135.0 Preclinical
CHEMBL525748 6.87 Ki 135.0 Preclinical
CHEMBL503520 6.76 Ki 172.0 Preclinical
CHEMBL455792 6.69 Ki 206.0 Preclinical
CHEMBL1813183 6.33 IC50 462.0 Preclinical
CHEMBL568525 6.01 Ki 968.0 Preclinical
CHEMBL500184 5.95 Ki 1133.0 Preclinical
Distribution

pChEMBL Value Distribution

2
5.0
3
5.5
2
6.0
4
6.5
1
7.0
1
7.5
0
8.0
0
8.5
0
9.0
1
9.5
pChEMBL
Assay Landscape

Assay Landscape

10
Total Assays
15
Tested Compounds
1
Assay Types
Binding — 10 assays, 15 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 7 9 6.2
cell-based format 3 6 6.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine